ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Livent, the lithium chemical spin-off of FMC, closed its initial public offering on the New York Stock Exchange on Thursday, Oct. 11, selling 20 million shares at $17.00 apiece, below its intended range of $18.00 to $20.00. In a weak stock market overall, Livent shares declined after their first day of trading and closed their first week at $16.25. The firm had $210 million in sales during the first six months of the year. FMC, which is focusing on agricultural chemicals, retains an 85% stake that it ultimately intends to distribute to shareholders.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X